InsidersTradesSigma
Expres2ion Biotech Holding AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Expres2ion Biotech Holding AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Expres2ion Biotech Holding AB has recorded 5 public disclosures. Market capitalisation: €15.3m. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: Teit Max Moscote Soegaard. Every trade is free.
5
Insider Decl.
0
Thresholds
€38,078
4 ops.
Buy Volume
€61,944
1 ops.
Sell Volume
41Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations5 total
225,615 shares0WarrantFI:csv-a2e2990c7cc1368134a1
Ideal exit: 30 Mar 2027 (T+270)
89,407 shares@ €0.14730.064% mcap100.0% of flowBTU (betald tecknad unit)FI:A003Y213-1
Ideal exit: 31 Jan 2027 (T+270)
156,250 shares@ €0.14760.11% mcap100.0% of flowBTU (betald tecknad unit)FI:A003Y068-1
Ideal exit: 26 Jan 2027 (T+270)
12,500 shares@ €0.14760.0089% mcap100.0% of flowBTU (betald tecknad unit)FI:A003Y075-1
Ideal exit: 25 Jan 2027 (T+270)
15,000 shares@ SEK 42.00100.0% of flowAktieFI:A001R218-1
5 of 5 declarations
About Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB is a company focused on developing biopharmaceutical solutions. It specializes in the production of recombinant proteins for therapeutic applications.